Abstract
In vivo microdialysis was used to compare the effects of β-endorphin upon dopamine (DA) release in the nucleus accumbens (NAC) of anesthetized versus freely moving rats, and to examine the role of the the mesolimbic DA system in mediating both the motoric and secondary reinforcing effects of this peptide. Microdialysis probes were inserted into the NAC and perfusates were analyzed for DA and its metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), using a reversed phase HPLC system with electrochemical detection for separation and quantification. Intracerebroventricular (ICV) administration of β-endorphin (2.5 and 5.0 µg) increased DA release and metabolites in both freely moving and anesthetized rats. This effect was of greater magnitude and duration in freely moving rats and was accompanied by stimulation of locomotor activity. The 5 µg dose also functioned as a secondary reinforcer in a conditioned place preference paradigm. A higher dose of β-endorphin (7.5 µg) stimulated DA release and metabolites in anesthetized rats but failed to affect these parameters in freely moving rats. At this dose, catalepsy and a loss of the reinforcing effects of this peptide were observed. These data demonstrate marked differences in the effects of β-endorphin upon DA release in the awake versus anesthetized rat. Further, the finding that the reinforcing and locomotor stimulating effects of β-endorphin only occur at those doses which stimulate DA release suggest that this action is critical for the expression of both behavioral effects.
Similar content being viewed by others
References
Amalric M, Cline EJ, Martinez JL, Bloom FE, Koob GF (1987) Rewarding properties of β-endorphin as measured by conditioned place preference. Psychopharmacology 91:14–20
Bals-Kubik R, Herz A, Shippenberg TS (1988) β-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids. Naunyn-Schmiedeberg's Arch Pharmacol 338:392–396
Bannon MJ, Roth RH (1983) Pharmacology of mesocortical dopamine neurons. Pharmacol Rev 35:53–69
Di Chiara G, Imperato A (1988a) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067–1078
Di Chiara G, Imperato A (1988b) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5280
Glick SD, Carlson JN, Baird JL, Maisonneuve IM, Bullock E (1988) Basal and amphetamine-induced asymmetries in striatal dopamine release and metabolism: bilateral in vivo microdialysis in normal rats. Brain Res 473:161–170
Hernandez L, Hoebel BG (1988) Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci 42:1705–1712
Herz A, Shippenberg TS (1989) Neurochemical aspects of addiction: Opioids and other drugs of abuse. In: Goldstein A (ed) Molecular and cellular aspects of the drug addictions. Springer, New York Berlin Heidelberg, pp 111–141
Iyengar S, Kim HS, Marien MR, McHugh D, Wood PL (1989) Modulation of mesolimbic dopaminergic projections by betaendorphin in the rat. Neuropharmacology 28:123–134
Kalivas PW, Widerlöv E, Stanley D, Breese G, Prange AJ (1983) Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther 227:229–237
Kelley AE, Stinus L, Iverson SD (1980) Interaction betweend-Ala-Met-enkephalin, A10 dopaminergic neurons, and spontaneous behavior in the rat. Behav Brain Res 1:3–24
Lohse M, Wuttke W (1981) Release and synthesis rates of catecholamines in hypothalamic, limbic and midbrain structures following intraventricular injections of beta-endorphin in male rats. Brain Res 229:389–398
Mansour A, Khachaturian H, Lewis ME, Akil H, Watson JS (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11:308–316
Morgenson GJ (1987) Limbic-motor integration. Prog Psychobiol Physiol Psychol 12:117–170
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Sydney
Phillipson OT, Griffiths AC (1985) The topographic order of inputs to nucleus accumbens in the rat. Neuroscience 16:275–286
Pijnenburg AJJ, Honig WMM, van Rossum JM (1973) Stimulation of motor activity following injection of dopamine into the nucleus accumbens. J Pharm Pharmacol 25:1003–1012
Pycock CJ, Cater CM, Kerwin RW (1980) Effect of 6-hydroxydopamine lesions in the medial prefrontal cortex on neuortransmitter systems in subcortical sites in the rat. J Neurochem 34:91–102
Shippenberg TS, Herz A (1988) Motivational effects of opioids: influence ofd-1 versusd-2 receptor antagonist. Eur J Pharmacol 151:233–241
Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734–1740
Spyraki C, Fibinger HC, Phillips AG (1983) Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology 79:278–283
Stinus L, Koob GF, Ling N, Bloom FE, Le Moal M (1980) Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions. Proc Natl Acad Sci USA 77:2323–2373
Taghzouti K, Simon H, Louilot A, Herman JP, Le Moal JM (1985) Behavioral study after local injection of 6-hydroxydopamine into the nucleus accumbens in the rat. Brain Res 344:9–20
Van Ree JM, Smyth DG, Colpaert FC (1979) Dependence creating properties of lipotropin c-fragment (β-endorphin): evidence for its internal control of behaviour. Life Sci 24:495–501
Wise RA (1983) Brain neuronal systems mediating reward processes. In: Smith JE, Lane JD (eds) The neurobiologiy of opiate reward processes. Elsevier Biomedical Press, Amsterdam, pp 405–428
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spanagel, R., Herz, A., Bals-Kubik, R. et al. β-Endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology 104, 51–56 (1991). https://doi.org/10.1007/BF02244553
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02244553